{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:46:57Z","timestamp":1793843217386,"version":"4.6.1"},"reference-count":49,"publisher":"The Endocrine Society","issue":"9","license":[{"start":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T00:00:00Z","timestamp":1616544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570710"],"award-info":[{"award-number":["81570710"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81500606"],"award-info":[{"award-number":["81500606"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Nanjing Medical Science and Technology Progressing","award":["ZKX15026"],"award-info":[{"award-number":["ZKX15026"]}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20170136"],"award-info":[{"award-number":["BK20170136"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20150090"],"award-info":[{"award-number":["BK20150090"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Regulatory T cell (Treg) dysfunction plays an important role in the development and progression of Graves\u2019 disease (GD). Programmed cell death 1 (PD-1) prompts FoxP3 in Treg expression and enhances the suppressive activity of Tregs. Whether abnormal expression of PD-1 contributes to the breakdown of Tregs and the role of thyroid hormone in the PD-1 expression of Tregs in GD remain substantially undefined.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To evaluate the role of PD-1 in Treg function and triiodothyronine (T3) in PD-1 expression in patients with GD and mice treated with T3.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We recruited 30 patients with GD and 30 healthy donors. PD-1 expression in Tregs and Treg function were determined. To evaluate the effects of thyroid hormone on PD-1 expression in Tregs, we used T3 for the treatment of human peripheral blood mononuclear cells (PBMCs). We then treated mice with T3 to confirm the effect of thyroid hormone on PD-1 expression in Tregs and Tregs function in vivo.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>PD-1 expression in Tregs and the suppressive function of Tregs significantly decreased in patients with GD. T3 reduced PD-1 expression in human Tregs in a concentration- and time-dependent manner in vitro. High levels of circulating T3 reduced PD-1 expression in Tregs, impaired Treg function, and disrupted T-helper cell (Th1 and Th2) balance in mice treated with T3.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Treg dysfunction in GD patients might be due to downregulation of PD-1 expression in Tregs induced by high levels of serum T3.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgab191","type":"journal-article","created":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T08:47:17Z","timestamp":1616575637000},"page":"2738-2753","source":"Crossref","is-referenced-by-count":21,"title":["High Levels of Thyroid Hormone Impair Regulatory T Cell Function Via Reduced PD-1 Expression"],"prefix":"10.1210","volume":"106","author":[{"given":"Yi","family":"Zhong","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Ting","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Mei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-Li","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Qing","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7485-5245","authenticated-orcid":false,"given":"Xiao-Ming","family":"Mao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2021,3,24]]},"reference":[{"key":"2021120108540572800_CIT0001","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","article-title":"Regulatory T cells: mechanisms of differentiation and function","volume":"30","author":"Josefowicz","year":"2012","journal-title":"Annu Rev Immunol."},{"key":"2021120108540572800_CIT0002","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/nyas.12011","article-title":"The life of regulatory T cells","volume":"1283","author":"Gratz","year":"2013","journal-title":"Ann N Y Acad Sci."},{"issue":"12","key":"2021120108540572800_CIT0003","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nri2889","article-title":"Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases","volume":"10","author":"Buckner","year":"2010","journal-title":"Nat Rev Immunol."},{"issue":"7169","key":"2021120108540572800_CIT0004","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nature06306","article-title":"The inhibitory cytokine IL-35 contributes to regulatory T-cell function","volume":"450","author":"Collison","year":"2007","journal-title":"Nature."},{"issue":"3","key":"2021120108540572800_CIT0005","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3109\/08916934.2012.751981","article-title":"Lower proportions of CD4+CD25(high) and CD4+FoxP3, but not CD4+CD25+CD127(low) FoxP3+ T cell levels in children with autoimmune thyroid diseases","volume":"46","author":"Bossowski","year":"2013","journal-title":"Autoimmunity."},{"issue":"9","key":"2021120108540572800_CIT0006","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1210\/jc.2005-2337","article-title":"Regulatory T cells in human autoimmune thyroid disease","volume":"91","author":"Marazuela","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"issue":"8","key":"2021120108540572800_CIT0007","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.4049\/jimmunol.0904135","article-title":"Impairment of regulatory capacity of CD4+CD25+ regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves\u2019 disease","volume":"186","author":"Mao","year":"2011","journal-title":"J Immunol."},{"issue":"4","key":"2021120108540572800_CIT0008","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1530\/EJE-11-0879","article-title":"Function of regulatory T-cells improved by dexamethasone in Graves\u2019 disease","volume":"166","author":"Hu","year":"2012","journal-title":"Eur J Endocrinol."},{"issue":"5","key":"2021120108540572800_CIT0009","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/intimm\/8.5.765","article-title":"Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes","volume":"8","author":"Agata","year":"1996","journal-title":"Int Immunol."},{"key":"2021120108540572800_CIT0010","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.0105-2896.2006.00414.x","article-title":"Regulatory T cells in the periphery","volume":"212","author":"Lohr","year":"2006","journal-title":"Immunol Rev."},{"issue":"13","key":"2021120108540572800_CIT0011","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1084\/jem.20090847","article-title":"PD-L1 regulates the development, maintenance, and function of induced regulatory T cells","volume":"206","author":"Francisco","year":"2009","journal-title":"J Exp Med."},{"issue":"7","key":"2021120108540572800_CIT0012","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/intimm\/dxm057","article-title":"PD-1 and PD-1 ligands: from discovery to clinical application","volume":"19","author":"Okazaki","year":"2007","journal-title":"Int Immunol."},{"issue":"3","key":"2021120108540572800_CIT0013","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/ni1443","article-title":"The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection","volume":"8","author":"Sharpe","year":"2007","journal-title":"Nat Immunol."},{"issue":"6","key":"2021120108540572800_CIT0014","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1530\/EJE-07-0649","article-title":"Association of an A\/C single nucleotide polymorphism in programmed cell death-ligand 1 gene with Graves\u2019 disease in Japanese patients","volume":"158","author":"Hayashi","year":"2008","journal-title":"Eur J Endocrinol."},{"issue":"1","key":"2021120108540572800_CIT0015","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2265.2007.02848.x","article-title":"Tag SNP screening of the PDCD1 gene for association with Graves\u2019 disease","volume":"67","author":"Newby","year":"2007","journal-title":"Clin Endocrinol (Oxf)."},{"key":"2021120108540572800_CIT0016","doi-asserted-by":"crossref","first-page":"102310","DOI":"10.1016\/j.jaut.2019.102310","article-title":"Balancing cancer immunotherapy and immune-related adverse events: the emerging role of regulatory T cells","volume":"104","author":"Alissafi","year":"2019","journal-title":"J Autoimmun."},{"key":"2021120108540572800_CIT0017","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.intimp.2018.04.021","article-title":"The risk of immune-related endocrine disorders associated with anti-PD-1 inhibitors therapy for solid tumors: a systematic review and meta-analysis","volume":"59","author":"Su","year":"2018","journal-title":"Int Immunopharmacol."},{"issue":"10047","key":"2021120108540572800_CIT0018","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0140-6736(16)00278-6","article-title":"Hyperthyroidism","volume":"388","author":"De Leo","year":"2016","journal-title":"Lancet."},{"key":"2021120108540572800_CIT0019","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3389\/fendo.2019.00486","article-title":"Thyroid hormone action on innate immunity","volume":"10","author":"Montesinos","year":"2019","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"10","key":"2021120108540572800_CIT0020","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1001\/jama.1995.03520340064038","article-title":"Treatment guidelines for patients with hyperthyroidism and hypothyroidism. Standards of Care Committee, American Thyroid Association","volume":"273","author":"Singer","year":"1995","journal-title":"Jama."},{"issue":"6","key":"2021120108540572800_CIT0021","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1089\/thy.2010.0417","article-title":"Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists","volume":"21","author":"Bahn Chair","year":"2011","journal-title":"Thyroid."},{"issue":"4","key":"2021120108540572800_CIT0022","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1530\/EC-18-0545","article-title":"Elevated thyroglobulin level is associated with dysfunction of regulatory T cells in patients with thyroid nodules","volume":"8","author":"Hu","year":"2019","journal-title":"Endocr Connect."},{"issue":"6","key":"2021120108540572800_CIT0023","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1096\/fj.11-193672","article-title":"Naturally occurring regulatory T cells: markers, mechanisms, and manipulation","volume":"26","author":"Schmetterer","year":"2012","journal-title":"FASEB J."},{"key":"2021120108540572800_CIT0024","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.imlet.2017.02.010","article-title":"Modulating the function of the immune system by thyroid hormones and thyrotropin","volume":"184","author":"Jara","year":"2017","journal-title":"Immunol Lett."},{"issue":"4","key":"2021120108540572800_CIT0025","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/cphy.c200003","article-title":"The role of thyroid hormone in the innate and adaptive immune response during infection","volume":"10","author":"Rubingh","year":"2020","journal-title":"Compr Physiol."},{"issue":"8","key":"2021120108540572800_CIT0026","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1089\/thy.2010.0429","article-title":"Thyroid hormones as modulators of immune activities at the cellular level","volume":"21","author":"De Vito","year":"2011","journal-title":"Thyroid."},{"key":"2021120108540572800_CIT0027","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3389\/fimmu.2018.01055","article-title":"Changes in nutritional status impact immune cell metabolism and function","volume":"9","author":"Alwarawrah","year":"2018","journal-title":"Front Immunol."},{"issue":"5","key":"2021120108540572800_CIT0028","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.smim.2016.09.006","article-title":"Metabolic control of immune tolerance in health and autoimmunity","volume":"28","author":"Carbone","year":"2016","journal-title":"Semin Immunol."},{"key":"2021120108540572800_CIT0029","first-page":"17","article-title":"Role of PD-1 in regulating T-cell immunity","volume":"350","author":"Jin","year":"2011","journal-title":"Curr Top Microbiol Immunol."},{"issue":"2","key":"2021120108540572800_CIT0030","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.immuni.2018.05.006","article-title":"PD-1 inhibitory receptor downregulates asparaginyl endopeptidase and maintains Foxp3 transcription factor stability in induced regulatory T cells","volume":"49","author":"Stathopoulou","year":"2018","journal-title":"Immunity."},{"issue":"30","key":"2021120108540572800_CIT0031","doi-asserted-by":"crossref","first-page":"8490","DOI":"10.1073\/pnas.1608873113","article-title":"Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model","volume":"113","author":"Zhang","year":"2016","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"1","key":"2021120108540572800_CIT0032","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s12020-014-0289-8","article-title":"Stress triggers the onset and the recurrences of hyperthyroidism in patients with Graves\u2019 disease","volume":"48","author":"Vita","year":"2015","journal-title":"Endocrine."},{"issue":"1","key":"2021120108540572800_CIT0033","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ncpendmet1006","article-title":"A patient with stress-related onset and exacerbations of Graves disease","volume":"5","author":"Vita","year":"2009","journal-title":"Nat Clin Pract Endocrinol Metab."},{"issue":"16","key":"2021120108540572800_CIT0034","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1056\/NEJMra1510030","article-title":"Graves\u2019 Disease","volume":"375","author":"Smith","year":"2016","journal-title":"N Engl J Med."},{"issue":"8","key":"2021120108540572800_CIT0035","first-page":"2986","article-title":"Graves\u2019 hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine\u2013a prospective, randomized study. Thyroid Study Group","volume":"81","author":"T\u00f6rring","year":"1996","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2021120108540572800_CIT0036","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1210\/jcem-58-1-62","article-title":"Similar effects of thionamide drugs and perchlorate on thyroid-stimulating immunoglobulins in Graves\u2019 disease: evidence against an immunosuppressive action of thionamide drugs","volume":"58","author":"Wenzel","year":"1984","journal-title":"J Clin Endocrinol Metab."},{"issue":"10","key":"2021120108540572800_CIT0037","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1089\/thy.2016.0652","article-title":"Long-term antithyroid drug treatment: a systematic review and meta-analysis","volume":"27","author":"Azizi","year":"2017","journal-title":"Thyroid."},{"issue":"9","key":"2021120108540572800_CIT0038","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1089\/thy.2019.0180","article-title":"Increased remission rates after long-term methimazole therapy in patients with graves\u2019 disease: results of a randomized clinical trial","volume":"29","author":"Azizi","year":"2019","journal-title":"Thyroid."},{"issue":"3","key":"2021120108540572800_CIT0039","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.autrev.2018.10.001","article-title":"The association of other autoimmune diseases in patients with Graves\u2019 disease (with or without ophthalmopathy): review of the literature and report of a large series","volume":"18","author":"Ferrari","year":"2019","journal-title":"Autoimmun Rev."},{"key":"2021120108540572800_CIT0040","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3389\/fendo.2018.00803","article-title":"The prevalence of thyroid disorders in patients with vitiligo: a systematic review and meta-analysis","volume":"9","author":"Yuan","year":"2018","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"1","key":"2021120108540572800_CIT0041","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.autrev.2014.10.002","article-title":"Regulatory T cells in vitiligo: implications for pathogenesis and therapeutics","volume":"14","author":"Dwivedi","year":"2015","journal-title":"Autoimmun Rev."},{"issue":"23","key":"2021120108540572800_CIT0042","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1016\/j.febslet.2011.07.043","article-title":"Regulatory T-cells in systemic lupus erythematosus and rheumatoid arthritis","volume":"585","author":"Chavele","year":"2011","journal-title":"FEBS Lett."},{"issue":"1","key":"2021120108540572800_CIT0043","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s10753-016-0470-8","article-title":"Foxp3, regulatory T cell, and autoimmune diseases","volume":"40","author":"Tao","year":"2017","journal-title":"Inflammation."},{"issue":"1","key":"2021120108540572800_CIT0044","first-page":"28","article-title":"Disturbed Th1 and Th2 balance in patients with Graves\u2019 disease","volume":"41","author":"Eshaghkhani","year":"2016","journal-title":"Minerva Endocrinol."},{"key":"2021120108540572800_CIT0045","first-page":"18","article-title":"Cells and tissues of the adaptive immune system","volume-title":"Cellular and Molecular Immunology.","author":"Abbas","year":"2007","edition":"6 ed"},{"issue":"6","key":"2021120108540572800_CIT0046","doi-asserted-by":"crossref","first-page":"457","DOI":"10.4158\/1934-2403-8.6.457","article-title":"American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism","volume":"8","author":"Baskin","year":"2002","journal-title":"Endocr Pract."},{"key":"2021120108540572800_CIT0047","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.mce.2017.03.006","article-title":"Frequencies of PD-1- positive T CD3+CD4+, T CD3+CD8+ and B CD19+ lymphocytes in female patients with Graves\u2019 disease and healthy controls \u2013 preliminary study","volume":"448","author":"Pyzik","year":"2017","journal-title":"Mol Cell Endocrinol."},{"key":"2021120108540572800_CIT0048","doi-asserted-by":"crossref","first-page":"102285","DOI":"10.1016\/j.jaut.2019.05.013","article-title":"Analysis of the PD-1\/PD-L1 axis in human autoimmune thyroid disease: Insights into pathogenesis and clues to immunotherapy associated thyroid autoimmunity","volume":"103","author":"\u00c1lvarez-Sierra","year":"2019","journal-title":"J Autoimmun."},{"issue":"11","key":"2021120108540572800_CIT0049","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2131\/jts.45.701","article-title":"PD-1\/PD-L1 affects Graves progression through lymphocytes on the proliferation, apoptosis and inflammatory cytokine secretion of thyroid follicular epithelial cells","volume":"45","author":"Han","year":"2020","journal-title":"J Toxicol Sci."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgab191\/38934989\/dgab191.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/106\/9\/2738\/41379437\/dgab191.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/106\/9\/2738\/41379437\/dgab191.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T13:41:59Z","timestamp":1638366119000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/106\/9\/2738\/6184614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,24]]},"references-count":49,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,3,24]]},"published-print":{"date-parts":[[2021,8,18]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgab191","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,9,1]]},"published":{"date-parts":[[2021,3,24]]}}}